首页 > 最新文献

Harefuah最新文献

英文 中文
[NOVEL CONCEPTS AND CHANGES IN TOTAL JOINT ARTHROPLASTY IN THE 21ST CENTURY]. [21世纪全关节置换术的新概念和变化]。
Pub Date : 2022-12-01
Yaniv Nur, Ran Atzmon, Tal Kalimian, Ohad Segal, Amir Herman, Michael Drexler

Introduction: Total joint arthroplasty (TJA) is amongst the most common elective orthopedic surgeries. Since their introduction in 1951 there have been changes not only in prosthesis design and surgical approaches, but also in patient management, anesthesia, drug regimen and robotic arm assistance. These changes led to advancement in patient safety and shorter hospitalization. Today TJA is accessible for a wider age and function range of patients, which has led to an exponential growth in the number of procedures conducted.

全关节置换术(TJA)是最常见的骨科手术之一。自1951年引进以来,假肢不仅在设计和手术方法上发生了变化,而且在病人管理、麻醉、药物治疗和机械臂辅助方面也发生了变化。这些变化提高了患者的安全性,缩短了住院时间。今天,TJA适用于更广泛的年龄和功能范围的患者,这导致了手术数量的指数级增长。
{"title":"[NOVEL CONCEPTS AND CHANGES IN TOTAL JOINT ARTHROPLASTY IN THE 21ST CENTURY].","authors":"Yaniv Nur,&nbsp;Ran Atzmon,&nbsp;Tal Kalimian,&nbsp;Ohad Segal,&nbsp;Amir Herman,&nbsp;Michael Drexler","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Total joint arthroplasty (TJA) is amongst the most common elective orthopedic surgeries. Since their introduction in 1951 there have been changes not only in prosthesis design and surgical approaches, but also in patient management, anesthesia, drug regimen and robotic arm assistance. These changes led to advancement in patient safety and shorter hospitalization. Today TJA is accessible for a wider age and function range of patients, which has led to an exponential growth in the number of procedures conducted.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 12","pages":"769-773"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9111591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PROLONGED POST-COVID-19 ANEMIA]. [covid -19后长期贫血]。
Pub Date : 2022-12-01
Yafit Segman, Adrian Duek, Yair Goldhechet, Marina Maklovsky, Michal Chipuck, Merav Leiba

Introduction: In February 2020, the World Health Organization (WHO) designated Covid-19 as a global pandemic, resulting in a growing population of individuals with a wide range of persistent symptoms after acute SARS-CoV-2 infection. According to the categories proposed by the WHO, the symptoms can be regarded as post-Covid if they developed during or after the Covid-19, continue >2 months and are not explained by an alternative diagnosis. Common persistent symptoms include fatigue, dyspnea, and decreased exercise capacity. Even though at diagnosis Covid- 19 has prominent hematologic manifestations, they mostly resolve after recovery from acute illness. We present a case of a 58-year-old male, without prior medical conditions, who developed a profound and prolonged anemia following mild Covid-19.

2020年2月,世界卫生组织(世卫组织)将Covid-19指定为全球大流行,导致急性SARS-CoV-2感染后出现各种持续性症状的个体数量不断增加。根据世卫组织提出的分类,如果症状在Covid-19期间或之后出现,持续2个月以上,并且没有其他诊断可以解释,则可视为Covid-19后症状。常见的持续性症状包括疲劳、呼吸困难和运动能力下降。尽管在诊断时Covid- 19有突出的血液学表现,但它们大多在急性疾病恢复后消退。我们报告了一例58岁男性,既往无医疗条件,在轻度Covid-19后出现了严重和长期贫血。
{"title":"[PROLONGED POST-COVID-19 ANEMIA].","authors":"Yafit Segman,&nbsp;Adrian Duek,&nbsp;Yair Goldhechet,&nbsp;Marina Maklovsky,&nbsp;Michal Chipuck,&nbsp;Merav Leiba","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>In February 2020, the World Health Organization (WHO) designated Covid-19 as a global pandemic, resulting in a growing population of individuals with a wide range of persistent symptoms after acute SARS-CoV-2 infection. According to the categories proposed by the WHO, the symptoms can be regarded as post-Covid if they developed during or after the Covid-19, continue >2 months and are not explained by an alternative diagnosis. Common persistent symptoms include fatigue, dyspnea, and decreased exercise capacity. Even though at diagnosis Covid- 19 has prominent hematologic manifestations, they mostly resolve after recovery from acute illness. We present a case of a 58-year-old male, without prior medical conditions, who developed a profound and prolonged anemia following mild Covid-19.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 12","pages":"732-735"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9111598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[UROLOGICAL CONSULT FOR PATIENT WITH RENAL COLIC BEFORE DISCHARGE FROM THE EMERGENCY DEPARTMENT (ED): THE OUTCOME EFFECT ON SPONTANEOUS STONE EXPULSION AND RE-VISIT TO ED]. [急诊科出院前肾绞痛患者的泌尿科会诊(ed):对自发性结石排出和再次就诊结果的影响]。
Pub Date : 2022-12-01
Amit Shemesh, Ben Shalom, Eyal Hen, Eyal Barkai, Fahed Atamna, Haitham Abu Nijmeh, Amir Cooper, Orit Raz

Introduction: Renal colic due to ureterolithiasis is a frequent reason for visiting the emergency departments (ED). The majority of those patients are managed non-surgically and will experience a spontaneous stone expulsion. The ED at our hospital works as a unified department, which is a well-established practice in Europe and North America.

Aims: Assess the outcome of urological consultation in the ED for patients with urolithiasis.

Methods: A retrospective cohort examined 402 ureterolithiasis patients proven by abdominal CT-scan at the ED. Patients were divided into 3 groups: Group1: patients were discharged after evaluation by ED physician alone. In Group 2: patients were discharged after being evaluated by an ED physician and urologist. In Group 3: patients who were admitted to the Urology Department. Clinical, laboratory and imaging parameters were examined as well as patients' outcomes: spontaneous stone expulsion, re-visit to ED and surgical intervention.

Results: There were not significant differences between group 1 and 2 regarding age, stone size, stone location, WBC levels, stone expulsion rate or surgical intervention. Group 1 had a significant higher rate of ED re-visits compared with group 2 (79 (43.3%) vs. 12 (17.9%). p=0.0002). Group 3 had significantly higher stone size, creatinine levels, inflammatory markers, proximal stone location and surgical interventions.

Conclusions: ED working as a unified department provides excellent management to patients with renal colic due to ureterolithiasis, with a high rate of spontaneous stone expulsion and urologist referral to admissions and surgical interventions. Nevertheless, urological consultation significantly decreases re-visits to ED.

导读:输尿管结石引起的肾绞痛是急诊科(ED)的常见原因。这些患者中的大多数是非手术治疗的,并且会经历自发的结石排出。我们医院的急诊科是一个统一的科室,这在欧洲和北美都是很好的做法。目的:评估尿石症患者在急诊科的泌尿科会诊结果。方法:回顾性分析402例经急诊科腹部ct扫描证实的输尿管结石患者,将患者分为3组:第一组:经急诊科医师单独评估出院。第二组:患者经急诊科医生和泌尿科医生评估后出院。第三组:入泌尿外科的患者。检查临床、实验室和影像学参数以及患者的结果:自发结石排出、再次就诊ED和手术干预。结果:1组和2组在年龄、结石大小、结石位置、白细胞水平、结石排出率或手术干预方面无显著差异。组1的ED复诊率明显高于组2(79例(43.3%)vs. 12例(17.9%)。p = 0.0002)。3组结石大小、肌酐水平、炎症标志物、近端结石位置和手术干预均显著高于对照组。结论:急诊科作为一个统一的科室,为输尿管结石所致肾绞痛患者提供了良好的管理,自发性结石排出率高,泌尿科医生转诊入院和手术干预率高。然而,泌尿科会诊显著减少了急诊室的复诊。
{"title":"[UROLOGICAL CONSULT FOR PATIENT WITH RENAL COLIC BEFORE DISCHARGE FROM THE EMERGENCY DEPARTMENT (ED): THE OUTCOME EFFECT ON SPONTANEOUS STONE EXPULSION AND RE-VISIT TO ED].","authors":"Amit Shemesh,&nbsp;Ben Shalom,&nbsp;Eyal Hen,&nbsp;Eyal Barkai,&nbsp;Fahed Atamna,&nbsp;Haitham Abu Nijmeh,&nbsp;Amir Cooper,&nbsp;Orit Raz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Renal colic due to ureterolithiasis is a frequent reason for visiting the emergency departments (ED). The majority of those patients are managed non-surgically and will experience a spontaneous stone expulsion. The ED at our hospital works as a unified department, which is a well-established practice in Europe and North America.</p><p><strong>Aims: </strong>Assess the outcome of urological consultation in the ED for patients with urolithiasis.</p><p><strong>Methods: </strong>A retrospective cohort examined 402 ureterolithiasis patients proven by abdominal CT-scan at the ED. Patients were divided into 3 groups: Group1: patients were discharged after evaluation by ED physician alone. In Group 2: patients were discharged after being evaluated by an ED physician and urologist. In Group 3: patients who were admitted to the Urology Department. Clinical, laboratory and imaging parameters were examined as well as patients' outcomes: spontaneous stone expulsion, re-visit to ED and surgical intervention.</p><p><strong>Results: </strong>There were not significant differences between group 1 and 2 regarding age, stone size, stone location, WBC levels, stone expulsion rate or surgical intervention. Group 1 had a significant higher rate of ED re-visits compared with group 2 (79 (43.3%) vs. 12 (17.9%). p=0.0002). Group 3 had significantly higher stone size, creatinine levels, inflammatory markers, proximal stone location and surgical interventions.</p><p><strong>Conclusions: </strong>ED working as a unified department provides excellent management to patients with renal colic due to ureterolithiasis, with a high rate of spontaneous stone expulsion and urologist referral to admissions and surgical interventions. Nevertheless, urological consultation significantly decreases re-visits to ED.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 12","pages":"751-756"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9106587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[COMPLETE ATRIOVENTRICULAR BLOCK DUE TO PULMONARY EMBOLISM]. [肺栓塞引起的完全性房室传导阻滞]。
Pub Date : 2022-12-01
Einat Shaked, Ella Yahud, Gergana Marincheva, Andrei Valdman, Eli I Lev, Avishag Laish-Farkash

Introduction: Pulmonary embolism, a common and potentially fatal clinical condition, occurs when a blood thrombus becomes lodged in the pulmonary vasculature and creates an acute increment in the pulmonary vascular resistance, which, in turn, creates a right ventricular strain. Among the more familiar electrocardiographic manifestations in acute pulmonary embolism is sinus tachycardia, right bundle branch block and ST-T abnormalities in the right precordium leads. Complete heart block or any type of bradycardia is uncommon. In our case report we present an 81 years old woman who was admitted to our institution with acute pulmonary embolism and complete atrioventricular block, which later resolved with appropriate anticoagulation therapy.

简介:肺栓塞是一种常见且可能致命的临床疾病,当血栓滞留在肺血管中并造成肺血管阻力的急性增加时,就会发生肺栓塞,这反过来又会造成右心室应变。急性肺栓塞较为常见的心电图表现为窦性心动过速、右束支传导阻滞和右心前导联ST-T异常。完全的心脏传导阻滞或任何类型的心动过缓是罕见的。在我们的病例报告中,我们介绍了一位81岁的女性,她因急性肺栓塞和完全性房室传导阻滞而入院,后来通过适当的抗凝治疗得以解决。
{"title":"[COMPLETE ATRIOVENTRICULAR BLOCK DUE TO PULMONARY EMBOLISM].","authors":"Einat Shaked,&nbsp;Ella Yahud,&nbsp;Gergana Marincheva,&nbsp;Andrei Valdman,&nbsp;Eli I Lev,&nbsp;Avishag Laish-Farkash","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Pulmonary embolism, a common and potentially fatal clinical condition, occurs when a blood thrombus becomes lodged in the pulmonary vasculature and creates an acute increment in the pulmonary vascular resistance, which, in turn, creates a right ventricular strain. Among the more familiar electrocardiographic manifestations in acute pulmonary embolism is sinus tachycardia, right bundle branch block and ST-T abnormalities in the right precordium leads. Complete heart block or any type of bradycardia is uncommon. In our case report we present an 81 years old woman who was admitted to our institution with acute pulmonary embolism and complete atrioventricular block, which later resolved with appropriate anticoagulation therapy.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 12","pages":"743-746"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9106585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[DEFERRED NEPHRECTOMY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA AFTER A NEAR-COMPLETE RESPONSE TO IMMUNOTHERAPY]. [一名对免疫治疗几乎完全反应的转移性肾癌患者的延迟肾切除术]。
Pub Date : 2022-12-01
Ofer Purim, Orit Raz, Alon Eisner, Nina Baram, Mia Leonov Polak, Larisa Rybo

Introduction: The treatment of newly diagnosed metastatic renal cell carcinoma (mRCC) evolved dramatically with the approval of immune checkpoint inhibitors (ICI) such as nivolumab, ipilimumab, and pembrolizumab for this indication. Herein, we describe the case of a 52-year old male patient, without chronic diseases and with a 30-pack-year smoking history, who was diagnosed with mRCC (clear cell carcinoma) including enlarged lymph nodes in the mediastinum, a mass in the pleura, and numerous metastases in both lungs. The patient was treated with a combination of nivolumab and ipilimumab, followed by nivolumab monotherapy, which is still ongoing (as of December 2021). The patient had a near-complete response (near resolution of the metastatic lesions) and did not experience adverse events. After 13 months of treatment, and in light of the near-complete response, the patient underwent a radical laparoscopic nephrectomy. The postoperative period was uneventful and the patient was discharged from the hospital 3 days after surgery. Examining the excised kidney revealed no residual tumor, connective tissue, signs of inflammation and necrosis. As of December 2021 (approximately 23 months from immunotherapy initiation) the patient had no evidence of disease. This case report demonstrates a treatment approach involving deferred nephrectomy after (and during) ICI treatment. The response of the patient described herein to a combination of nivolumab and ipilimumab is consistent with the available data supporting the efficacy of this combination as a first-line therapy in mRCC. Currently, the evidence supporting deferred nephrectomy (after ICI) vs upfront nephrectomy and then ICI, or ICI alone without nephrectomy is limited to a few retrospective studies. Thus, prospective randomized studies are needed to elucidate the role of deferred nephrectomy in mRCC. Two phase 3 studies (PROBE and NORDIC-SUN) that were designed to address this issue are currently enrolling patients and their results are expected within several years.

随着免疫检查点抑制剂(ICI)如nivolumab、ipilimumab和pembrolizumab被批准用于这一适应症,新诊断的转移性肾细胞癌(mRCC)的治疗发生了巨大变化。在此,我们描述了一个52岁的男性患者,没有慢性疾病,有30包年的吸烟史,被诊断为mRCC(透明细胞癌),包括纵隔淋巴结肿大,胸膜肿块,双肺大量转移。患者接受纳武单抗和伊匹单抗联合治疗,随后接受纳武单抗单药治疗,该治疗仍在进行中(截至2021年12月)。患者有一个近乎完全的反应(转移性病变接近解决),没有经历不良事件。经过13个月的治疗,鉴于几乎完全的反应,患者接受了根治性腹腔镜肾切除术。术后顺利,患者于术后3天出院。检查切除的肾脏未发现残留肿瘤、结缔组织、炎症和坏死迹象。截至2021年12月(免疫治疗开始后约23个月),患者无疾病证据。本病例报告展示了在ICI治疗后(和期间)延期肾切除术的治疗方法。本文描述的患者对纳武单抗和伊匹单抗联合治疗的反应与支持该联合治疗作为mRCC一线治疗的有效性的现有数据一致。目前,支持延迟肾切除术(先行肾切除术后行肾切除术)vs先行肾切除术后行肾切除术,或仅行肾切除术而不行肾切除术的证据仅限于少数回顾性研究。因此,需要前瞻性随机研究来阐明延迟肾切除术在mRCC中的作用。两项旨在解决这一问题的3期研究(PROBE和NORDIC-SUN)目前正在招募患者,预计将在几年内得出结果。
{"title":"[DEFERRED NEPHRECTOMY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA AFTER A NEAR-COMPLETE RESPONSE TO IMMUNOTHERAPY].","authors":"Ofer Purim,&nbsp;Orit Raz,&nbsp;Alon Eisner,&nbsp;Nina Baram,&nbsp;Mia Leonov Polak,&nbsp;Larisa Rybo","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The treatment of newly diagnosed metastatic renal cell carcinoma (mRCC) evolved dramatically with the approval of immune checkpoint inhibitors (ICI) such as nivolumab, ipilimumab, and pembrolizumab for this indication. Herein, we describe the case of a 52-year old male patient, without chronic diseases and with a 30-pack-year smoking history, who was diagnosed with mRCC (clear cell carcinoma) including enlarged lymph nodes in the mediastinum, a mass in the pleura, and numerous metastases in both lungs. The patient was treated with a combination of nivolumab and ipilimumab, followed by nivolumab monotherapy, which is still ongoing (as of December 2021). The patient had a near-complete response (near resolution of the metastatic lesions) and did not experience adverse events. After 13 months of treatment, and in light of the near-complete response, the patient underwent a radical laparoscopic nephrectomy. The postoperative period was uneventful and the patient was discharged from the hospital 3 days after surgery. Examining the excised kidney revealed no residual tumor, connective tissue, signs of inflammation and necrosis. As of December 2021 (approximately 23 months from immunotherapy initiation) the patient had no evidence of disease. This case report demonstrates a treatment approach involving deferred nephrectomy after (and during) ICI treatment. The response of the patient described herein to a combination of nivolumab and ipilimumab is consistent with the available data supporting the efficacy of this combination as a first-line therapy in mRCC. Currently, the evidence supporting deferred nephrectomy (after ICI) vs upfront nephrectomy and then ICI, or ICI alone without nephrectomy is limited to a few retrospective studies. Thus, prospective randomized studies are needed to elucidate the role of deferred nephrectomy in mRCC. Two phase 3 studies (PROBE and NORDIC-SUN) that were designed to address this issue are currently enrolling patients and their results are expected within several years.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 12","pages":"763-768"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9481645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ANCHORLESS VAGINAL IMPLANT FOR THE TREATMENT OF ADVANCED PELVIC ORGAN PROLAPSE]. [用于治疗晚期盆腔器官脱垂的无锚阴道植入物]。
Pub Date : 2022-12-01
Gil Levy, Anat Beck, Yanai Zines, Michal Shaubi-Rosen, Ofer Shemer, Moti Pansky

Introduction: The use of vaginal mesh in pelvic surgery has previously demonstrated anatomical advantage combined with surgical complications that have called its effectiveness into question.

Objectives: To evaluate the safety and efficacy of an anchorless implant for the repair of pelvic organ prolapse (POP) in women with risk factors for recurrence.

Methods: Retrospective evaluation of the self-retaining support (SRS) implant in women with a ≥2 degree vaginal anterior and apical prolapse with an increased risk of prolapse recurrence. Demographic and clinical data were collected, and women suspected of recurrence, based on a telephone questionnaire, were re-examined.

Results: Sixty women were evaluated. Four (6.6%) underwent reoperation due to prolapse recurrence of the posterior and vaginal apex. No intra-operative complications were documented; 4 (6.6%) women had surgical field hematoma treated conservatively. No chronic pelvic pain or dyspareunia were documented. Six (10%) women who reported bulging sensation in the telephone questionnaire were examined and found to have prolapse of the posterior compartment and not of the anterior or apical compartment treated by the SRS.

Conclusions: Use of the SRS demonstrated 93.3% success rate at a mean follow-up of 14 months postoperatively without intra-operative complications and mild post-op complications at follow-up.

Discussion: Short term data on the use of the SRS demonstrate that anchorless mesh technique may preserve the benefits of vaginal mesh while eliminating surgical complications. The SRS is a safe and effective surgical alternative for the repair of anterior and apical vaginal prolapse in women with advanced pelvic organ prolapse and risk factors for relapse.

简介:在盆腔手术中使用阴道网片曾显示出解剖学上的优势,但手术并发症却使其有效性受到质疑:目的:评估无锚植入物在具有复发风险因素的妇女中修复盆腔器官脱垂(POP)的安全性和有效性:方法:在阴道前壁和顶端脱垂≥2度且脱垂复发风险较高的妇女中,对自锁式支撑(SRS)植入物进行回顾性评估。我们收集了人口统计学和临床数据,并根据电话问卷对疑似复发的妇女进行了复查:结果:对 60 名妇女进行了评估。结果:共对 60 名妇女进行了评估,其中 4 人(6.6%)因后部和阴道顶端脱垂复发而接受了再次手术。没有术中并发症的记录;4名(6.6%)妇女的手术野血肿得到了保守治疗。没有慢性盆腔疼痛或排便困难的记录。6名(10%)在电话问卷中报告有膨出感的女性接受了检查,发现她们是后部脱垂,而非SRS治疗的前部或顶部脱垂:结论:在术后平均14个月的随访中,SRS的成功率为93.3%,术中无并发症,术后随访也无轻微并发症:讨论:使用 SRS 的短期数据表明,无锚网片技术可以保留阴道网片的优点,同时消除手术并发症。对于有盆腔器官脱垂和复发风险因素的晚期妇女来说,SRS 是修复前部和顶部阴道脱垂的一种安全有效的手术选择。
{"title":"[ANCHORLESS VAGINAL IMPLANT FOR THE TREATMENT OF ADVANCED PELVIC ORGAN PROLAPSE].","authors":"Gil Levy, Anat Beck, Yanai Zines, Michal Shaubi-Rosen, Ofer Shemer, Moti Pansky","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The use of vaginal mesh in pelvic surgery has previously demonstrated anatomical advantage combined with surgical complications that have called its effectiveness into question.</p><p><strong>Objectives: </strong>To evaluate the safety and efficacy of an anchorless implant for the repair of pelvic organ prolapse (POP) in women with risk factors for recurrence.</p><p><strong>Methods: </strong>Retrospective evaluation of the self-retaining support (SRS) implant in women with a ≥2 degree vaginal anterior and apical prolapse with an increased risk of prolapse recurrence. Demographic and clinical data were collected, and women suspected of recurrence, based on a telephone questionnaire, were re-examined.</p><p><strong>Results: </strong>Sixty women were evaluated. Four (6.6%) underwent reoperation due to prolapse recurrence of the posterior and vaginal apex. No intra-operative complications were documented; 4 (6.6%) women had surgical field hematoma treated conservatively. No chronic pelvic pain or dyspareunia were documented. Six (10%) women who reported bulging sensation in the telephone questionnaire were examined and found to have prolapse of the posterior compartment and not of the anterior or apical compartment treated by the SRS.</p><p><strong>Conclusions: </strong>Use of the SRS demonstrated 93.3% success rate at a mean follow-up of 14 months postoperatively without intra-operative complications and mild post-op complications at follow-up.</p><p><strong>Discussion: </strong>Short term data on the use of the SRS demonstrate that anchorless mesh technique may preserve the benefits of vaginal mesh while eliminating surgical complications. The SRS is a safe and effective surgical alternative for the repair of anterior and apical vaginal prolapse in women with advanced pelvic organ prolapse and risk factors for relapse.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 12","pages":"736-742"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9111593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[PANCREATIC NEUROENDOCRINE TUMORS (PNET): THE DILEMMA OF SURGERY VS. WATCHFUL WAITING APPROACH]. 胰腺神经内分泌肿瘤(pnet):手术与观察等待的两难选择。
Pub Date : 2022-11-01
May Shafir, Reut Harel, Veronica Sandler, Riad Haddad, Wisam Khoury, Arie Bitterman

Introduction: Neuroendocrine tumors (NEN) originate from hormone producing cells located in various organs and tissues. NEN are unique tumors in terms of their diverse and particular clinical presentations, growth pattern, location and relatively good prognosis. NEN can be either secreting or non-secreting tumors. The clinical presentation and symptoms are according to the specific hormone produced by the tumor. A non-secreting tumor will eventually cause symptoms that relate to a mass-effect or a metastatic disease. There are various familial and genetic syndromes that are related to NEN. The most common neuroendocrine genetic syndrome is Multiple Endocrine Neoplasia syndrome type 1 (MEN 1). The clinical approach and treatment of NEN are unlike any other cancer. The gold standard management is surgery but unlike other cancerous diseases, surgical intervention is also indicated in cases of metastatic disease. There are several surgical approaches, and they all depend on tumor size, location, grade, stage, lymph node involvement, remote metastases and patients' age and comorbidities. Besides surgery, some cases are also treated with systemic therapies such as Somatostatin analogues, chemotherapy, immunotherapies, targeted therapies and occasionally radiation therapy is used. In the last decade there is a significant increase in the number of patients diagnosed with small non-secreting pancreatic tumors (PNET) due to advanced imaging techniques and diagnostic tools. This incidental increase is the reason for the emerging dilemma of whether to operate or merely conduct a watchful waiting policy. Small non-secreting tumors are commonly not considered malignant and thus the question is if surgery is always the right approach. The benefits of surgery must be carefully considered against the potential damage that may occur during these complex and radical procedures. Moreover, new and progressive systemic pharmacological therapies are now available to efficiently suppress tumor hormonal secretion. Recent studies have challenged surgery as the only treatment of choice, and in some cases suggest conservative treatment and follow up. The aim of this present literature review is to describe PNET diagnostic tools and evaluation, and to examine the different approaches of PNET treatment.

神经内分泌肿瘤(Neuroendocrine tumor, NEN)起源于多种器官和组织中产生激素的细胞。NEN是一种独特的肿瘤,其临床表现多样,生长方式独特,位置独特,预后较好。NEN可以是分泌性或非分泌性肿瘤。临床表现和症状根据肿瘤产生的特定激素而定。非分泌性肿瘤最终会引起与肿块效应或转移性疾病相关的症状。有各种家族性和遗传性综合征与NEN有关。最常见的神经内分泌遗传综合征是1型多发性内分泌瘤变综合征(MEN 1)。NEN的临床方法和治疗不同于任何其他癌症。金标准管理是手术,但与其他癌症疾病不同,手术干预也适用于转移性疾病。有几种手术方法,它们都取决于肿瘤的大小,位置,分级,分期,淋巴结受累,远处转移和患者的年龄和合并症。除手术外,一些病例还接受全身治疗,如生长抑素类似物、化疗、免疫治疗、靶向治疗,偶尔也使用放射治疗。在过去的十年中,由于先进的成像技术和诊断工具,诊断为小非分泌性胰腺肿瘤(PNET)的患者数量显着增加。这种偶然的增加导致了一种困境的出现,即是实施还是仅仅实施一种观望的等待政策。小的非分泌性肿瘤通常不被认为是恶性的,因此问题是手术是否总是正确的方法。必须仔细考虑手术的好处,以防止在这些复杂和激进的手术中可能发生的潜在损害。此外,新的和渐进的系统药物治疗现在可以有效地抑制肿瘤激素的分泌。最近的研究质疑手术是唯一的治疗选择,在某些情况下建议保守治疗和随访。本文献综述的目的是描述PNET的诊断工具和评估,并检查PNET治疗的不同方法。
{"title":"[PANCREATIC NEUROENDOCRINE TUMORS (PNET): THE DILEMMA OF SURGERY VS. WATCHFUL WAITING APPROACH].","authors":"May Shafir,&nbsp;Reut Harel,&nbsp;Veronica Sandler,&nbsp;Riad Haddad,&nbsp;Wisam Khoury,&nbsp;Arie Bitterman","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Neuroendocrine tumors (NEN) originate from hormone producing cells located in various organs and tissues. NEN are unique tumors in terms of their diverse and particular clinical presentations, growth pattern, location and relatively good prognosis. NEN can be either secreting or non-secreting tumors. The clinical presentation and symptoms are according to the specific hormone produced by the tumor. A non-secreting tumor will eventually cause symptoms that relate to a mass-effect or a metastatic disease. There are various familial and genetic syndromes that are related to NEN. The most common neuroendocrine genetic syndrome is Multiple Endocrine Neoplasia syndrome type 1 (MEN 1). The clinical approach and treatment of NEN are unlike any other cancer. The gold standard management is surgery but unlike other cancerous diseases, surgical intervention is also indicated in cases of metastatic disease. There are several surgical approaches, and they all depend on tumor size, location, grade, stage, lymph node involvement, remote metastases and patients' age and comorbidities. Besides surgery, some cases are also treated with systemic therapies such as Somatostatin analogues, chemotherapy, immunotherapies, targeted therapies and occasionally radiation therapy is used. In the last decade there is a significant increase in the number of patients diagnosed with small non-secreting pancreatic tumors (PNET) due to advanced imaging techniques and diagnostic tools. This incidental increase is the reason for the emerging dilemma of whether to operate or merely conduct a watchful waiting policy. Small non-secreting tumors are commonly not considered malignant and thus the question is if surgery is always the right approach. The benefits of surgery must be carefully considered against the potential damage that may occur during these complex and radical procedures. Moreover, new and progressive systemic pharmacological therapies are now available to efficiently suppress tumor hormonal secretion. Recent studies have challenged surgery as the only treatment of choice, and in some cases suggest conservative treatment and follow up. The aim of this present literature review is to describe PNET diagnostic tools and evaluation, and to examine the different approaches of PNET treatment.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 11","pages":"687-694"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10457255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[CONFIDENTIALITY OF ADVERSE EVENTS INVESTIGATIONS - THE PRESENT STATUS AND WHAT IS NEEDED]. [不良事件调查的保密性-现状和需要]。
Pub Date : 2022-11-01
Yaron Niv, Ilia Kagan, Dana Arad, Riki Avrahami, Yossi Tal

Introduction: The goal of the medical staff is to provide proper, effective and efficient treatment to the patient and to take care of his well-being. An error in medical care that causes a serious outcome or mortality, can be considered negligence when the caregiver did not meet the requirements of a reasonable physician for reasonable care and did not take the necessary precautions in providing the treatment, in light of the information available to him. The perception of punishment and compensation due to harm, caused to a patient as a result of a medical error, changed dramatically over the years. Starting with direct and severe punishment according to Hammurabi laws and ending with the "no fault" approach that is accepted widely in some countries. Following an adverse event that occurred in medical treatment, a process should be conducted in order to draw lessons to reduce the likelihood of recurrence of similar incidents in the future, by answering 4 questions: What happened? How did it happen? Why did it happen? and What should be done to prevent similar incidents in the future? The Patient Rights Act does not suggest conducting a safety investigation but recommends an examination board in cases of negligence or error in treatment. By law, the protocols of the examination board are confidential and can be removed by the court in case the protocol contains evidence of importance that is unlikely to be found in the medical record. Lack of confidentiality may cause medical staff to be reluctant of conducting a safety investigation due to fear of using its findings for a lawsuit or appointing an examination board whose conclusions will be reported to the victim and his family. The "no fault" method overcomes these barriers by enabling a thorough safety investigation and has important professional, economic and social aspects with a direct impact on the quality and safety of treatment. The method expands the accessibility of victims to compensation, reduces the number of claims and the burden on the courts. Among additional benefits are transparency and consistency in decisions, promoting patient safety due to physicians' willingness to report failures, reduction in "defensive medicine" and spending in the health care system.

简介:医务人员的目标是为病人提供适当、有效和高效率的治疗,并照顾他的健康。如果护理人员没有满足合理医生对合理护理的要求,也没有根据所掌握的信息在提供治疗时采取必要的预防措施,则导致严重后果或死亡的医疗差错可被视为疏忽。多年来,由于医疗失误对病人造成伤害而对其进行惩罚和赔偿的观念发生了巨大变化。根据汉谟拉比法,以直接和严厉的惩罚开始,以在一些国家广泛接受的“无过错”方法结束。在医疗过程中发生不良事件后,应通过回答4个问题进行流程,以吸取教训,减少未来类似事件再次发生的可能性:发生了什么?这是怎么发生的?为什么会这样呢?应该做些什么来防止将来发生类似的事件?《患者权利法》没有规定进行安全调查,但建议在治疗疏忽或错误的情况下成立检查委员会。根据法律,检查委员会的记录是保密的,如果记录中载有不太可能在医疗记录中找到的重要证据,法院可以将其删除。由于缺乏保密性,医务人员可能不愿进行安全调查,因为他们害怕将调查结果用于诉讼或任命一个检查委员会,其结论将报告给受害者及其家属。“无过错”方法克服了这些障碍,能够进行彻底的安全调查,对治疗的质量和安全具有重要的专业、经济和社会方面的影响。该方法扩大了受害者获得赔偿的机会,减少了索赔的数量和法院的负担。其他好处包括决策的透明度和一致性,由于医生愿意报告失败而促进患者安全,减少“防御性医疗”和卫生保健系统的支出。
{"title":"[CONFIDENTIALITY OF ADVERSE EVENTS INVESTIGATIONS - THE PRESENT STATUS AND WHAT IS NEEDED].","authors":"Yaron Niv,&nbsp;Ilia Kagan,&nbsp;Dana Arad,&nbsp;Riki Avrahami,&nbsp;Yossi Tal","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The goal of the medical staff is to provide proper, effective and efficient treatment to the patient and to take care of his well-being. An error in medical care that causes a serious outcome or mortality, can be considered negligence when the caregiver did not meet the requirements of a reasonable physician for reasonable care and did not take the necessary precautions in providing the treatment, in light of the information available to him. The perception of punishment and compensation due to harm, caused to a patient as a result of a medical error, changed dramatically over the years. Starting with direct and severe punishment according to Hammurabi laws and ending with the \"no fault\" approach that is accepted widely in some countries. Following an adverse event that occurred in medical treatment, a process should be conducted in order to draw lessons to reduce the likelihood of recurrence of similar incidents in the future, by answering 4 questions: What happened? How did it happen? Why did it happen? and What should be done to prevent similar incidents in the future? The Patient Rights Act does not suggest conducting a safety investigation but recommends an examination board in cases of negligence or error in treatment. By law, the protocols of the examination board are confidential and can be removed by the court in case the protocol contains evidence of importance that is unlikely to be found in the medical record. Lack of confidentiality may cause medical staff to be reluctant of conducting a safety investigation due to fear of using its findings for a lawsuit or appointing an examination board whose conclusions will be reported to the victim and his family. The \"no fault\" method overcomes these barriers by enabling a thorough safety investigation and has important professional, economic and social aspects with a direct impact on the quality and safety of treatment. The method expands the accessibility of victims to compensation, reduces the number of claims and the burden on the courts. Among additional benefits are transparency and consistency in decisions, promoting patient safety due to physicians' willingness to report failures, reduction in \"defensive medicine\" and spending in the health care system.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 11","pages":"701-705"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10800135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[ON PHYSICIAN -ASSISTANT AND OTHER ALLIED HEALTH PROFESSIONS]. [关于医师助理和其他相关卫生职业]。
Pub Date : 2022-11-01
Avi Ohry

Introduction: During the late 19th century and the 20th century, many allied health and technical professions, joined physicians and nurses in their formal medical and surgical comprehensive work. The professionalization process of the various medical and surgical fields demanded true incorporation of allied health professions into the medical infrastructure. Non-academic professions such as the "feldsher ", barber-surgeon, bone-setters and the midwife, transferred into realms of the academic medical and the health professions fields.

在19世纪末和20世纪,许多联合卫生和技术专业,加入医生和护士的正式医疗和外科综合工作。各种医疗和外科领域的专业化进程要求将联合卫生专业人员真正纳入医疗基础设施。非学术职业,如"长工"、理发外科医生、接骨师和助产士,转移到学术医学和卫生专业领域。
{"title":"[ON PHYSICIAN -ASSISTANT AND OTHER ALLIED HEALTH PROFESSIONS].","authors":"Avi Ohry","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>During the late 19th century and the 20th century, many allied health and technical professions, joined physicians and nurses in their formal medical and surgical comprehensive work. The professionalization process of the various medical and surgical fields demanded true incorporation of allied health professions into the medical infrastructure. Non-academic professions such as the \"feldsher \", barber-surgeon, bone-setters and the midwife, transferred into realms of the academic medical and the health professions fields.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 11","pages":"718-720"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10509819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[THE HISTORY OF THE ISRAELI YEARLY NEURO-OPHTHALMOLOGY MEETING - 25TH ANNIVERSARY]. [以色列年度神经眼科会议的历史- 25周年纪念]。
Pub Date : 2022-11-01
Riri Sylvia Manor

Introduction: This paper describes the difficulties to create a new Israeli annual meeting, 25 years ago, with the annual participation of the world's best neuro-ophthalmologists. This meeting contributed to the increase in the number of neuro-ophthalmologists in Israel, improved local knowledge, as well as the scientific research in this particular field, and changed the status of the Israeli neuro-ophthalmology on the international neuro-ophthalmology map.

引言:这篇论文描述了25年前创建一个新的以色列年会的困难,每年都有世界上最好的神经眼科医生参加。这次会议增加了以色列神经眼科医生的数量,提高了当地的知识,以及在这一特定领域的科学研究,并改变了以色列神经眼科在国际神经眼科地图上的地位。
{"title":"[THE HISTORY OF THE ISRAELI YEARLY NEURO-OPHTHALMOLOGY MEETING - 25TH ANNIVERSARY].","authors":"Riri Sylvia Manor","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>This paper describes the difficulties to create a new Israeli annual meeting, 25 years ago, with the annual participation of the world's best neuro-ophthalmologists. This meeting contributed to the increase in the number of neuro-ophthalmologists in Israel, improved local knowledge, as well as the scientific research in this particular field, and changed the status of the Israeli neuro-ophthalmology on the international neuro-ophthalmology map.</p>","PeriodicalId":12965,"journal":{"name":"Harefuah","volume":"161 11","pages":"714-717"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10509818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Harefuah
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1